Literature DB >> 26283074

Identifying the role of pre-and postsynaptic GABA(B) receptors in behavior.

Chelsea R Kasten1, Stephen L Boehm2.   

Abstract

Although many reviews exist characterizing the molecular differences of GABAB receptor isoforms, there is no current review of the in vivo effects of these isoforms. The current review focuses on whether the GABAB1a and GABAB1b isoforms contribute differentially to behaviors in isoform knockout mice. The roles of these receptors have primarily been characterized in cognitive, anxiety, and depressive phenotypes. Currently, the field supports a role of GABAB1a in memory maintenance and protection against an anhedonic phenotype, whereas GABAB1b appears to be involved in memory formation and a susceptibility to developing an anhedonic phenotype. Although GABAB receptors have been strongly implicated in drug abuse phenotypes, no isoform-specific work has been done in this field. Future directions include developing site-specific isoform knockdown to identify the role of different brain regions in behavior, as well as identifying how these isoforms are involved in development of behavioral phenotypes.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cognition; Depression; Drugs of abuse; GABA(B) receptor; Isoform; Knockout

Mesh:

Substances:

Year:  2015        PMID: 26283074      PMCID: PMC4548832          DOI: 10.1016/j.neubiorev.2015.08.007

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  86 in total

1.  GABA(B) auto- versus hetero-receptor sensitivity: implications for novel pharmacotherapy.

Authors:  B Yu; K Yamada; J P Gallagher
Journal:  Neuropharmacology       Date:  1999-11       Impact factor: 5.250

2.  Differential expression of gamma-aminobutyric acid type B receptor-1a and -1b mRNA variants in GABA and non-GABAergic neurons of the rat brain.

Authors:  F Liang; Y Hatanaka; H Saito; T Yamamori; T Hashikawa
Journal:  J Comp Neurol       Date:  2000-01-24       Impact factor: 3.215

3.  Generalization of amygdala LTP and conditioned fear in the absence of presynaptic inhibition.

Authors:  Hamdy Shaban; Yann Humeau; Cyril Herry; Guillaume Cassasus; Ryuichi Shigemoto; Stephane Ciocchi; Samuel Barbieri; Herman van der Putten; Klemens Kaupmann; Bernhard Bettler; Andreas Lüthi
Journal:  Nat Neurosci       Date:  2006-07-02       Impact factor: 24.884

Review 4.  GABA(B) receptors and synaptic modulation.

Authors:  Hans-Christian Kornau
Journal:  Cell Tissue Res       Date:  2006-08-25       Impact factor: 5.249

5.  Behavioral evaluation of mice deficient in GABA(B(1)) receptor isoforms in tests of unconditioned anxiety.

Authors:  Laura H Jacobson; Bernhard Bettler; Klemens Kaupmann; John F Cryan
Journal:  Psychopharmacology (Berl)       Date:  2006-12-15       Impact factor: 4.530

6.  GABAB1 receptor subunit isoforms exert a differential influence on baseline but not GABAB receptor agonist-induced changes in mice.

Authors:  Laura H Jacobson; Bernhard Bettler; Klemens Kaupmann; John F Cryan
Journal:  J Pharmacol Exp Ther       Date:  2006-09-21       Impact factor: 4.030

Review 7.  Animal models of anxiety and depression: how are females different?

Authors:  P Palanza
Journal:  Neurosci Biobehav Rev       Date:  2001-05       Impact factor: 8.989

8.  Characterization of [(3)H]-CGP54626A binding to heterodimeric GABA(B) receptors stably expressed in mammalian cells.

Authors:  A Green; S Walls; A Wise; R H Green; A K Martin; F H Marshall
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

9.  GABA(B(1)) receptor isoforms differentially mediate the acquisition and extinction of aversive taste memories.

Authors:  Laura H Jacobson; Peter H Kelly; Bernhard Bettler; Klemens Kaupmann; John F Cryan
Journal:  J Neurosci       Date:  2006-08-23       Impact factor: 6.167

10.  GABA(B) receptor-positive modulation decreases selective molecular and behavioral effects of cocaine.

Authors:  Loic Lhuillier; Cedric Mombereau; John F Cryan; Klemens Kaupmann
Journal:  Neuropsychopharmacology       Date:  2006-05-17       Impact factor: 7.853

View more
  7 in total

1.  Deficits in the activity of presynaptic γ-aminobutyric acid type B receptors contribute to altered neuronal excitability in fragile X syndrome.

Authors:  Ji-Yong Kang; Jayashree Chadchankar; Thuy N Vien; Michelle I Mighdoll; Thomas M Hyde; Robert J Mather; Tarek Z Deeb; Menelas N Pangalos; Nicholas J Brandon; John Dunlop; Stephen J Moss
Journal:  J Biol Chem       Date:  2017-02-17       Impact factor: 5.157

Review 2.  Function of the GABAergic System in Diabetic Encephalopathy.

Authors:  Hongli Zhou; Zhili Rao; Zuo Zhang; Jiyin Zhou
Journal:  Cell Mol Neurobiol       Date:  2022-04-23       Impact factor: 5.046

3.  Allopregnanolone Treatment Improves Plasma Metabolomic Profile Associated with GABA Metabolism in Fragile X-Associated Tremor/Ataxia Syndrome: a Pilot Study.

Authors:  Eleonora Napoli; Andrea Schneider; Jun Yi Wang; Aditi Trivedi; Nika Roa Carrillo; Flora Tassone; Michael Rogawski; Randi J Hagerman; Cecilia Giulivi
Journal:  Mol Neurobiol       Date:  2018-09-05       Impact factor: 5.590

Review 4.  Succinic semialdehyde dehydrogenase deficiency (SSADHD): Pathophysiological complexity and multifactorial trait associations in a rare monogenic disorder of GABA metabolism.

Authors:  P Malaspina; J-B Roullet; P L Pearl; G R Ainslie; K R Vogel; K M Gibson
Journal:  Neurochem Int       Date:  2016-06-14       Impact factor: 3.921

Review 5.  Mechanisms and Regulation of Neuronal GABAB Receptor-Dependent Signaling.

Authors:  Timothy R Rose; Kevin Wickman
Journal:  Curr Top Behav Neurosci       Date:  2022

6.  Effects of GABAB receptor activation on spatial cognitive function and hippocampal neurones in rat models of type 2 diabetes mellitus.

Authors:  Xiao-Jun Cai; Lei Wang; Chun-Mei Hu
Journal:  Biosci Rep       Date:  2018-01-19       Impact factor: 3.840

7.  Dose-Response Effect of Antibodies to S100 Protein and Cannabinoid Receptor Type 1 in Released-Active Form in the Light-Dark Test in Mice.

Authors:  Elena V Kardash; Irina A Ertuzun; Gul'nara R Khakimova; Andrey N Kolyadin; Sergey A Tarasov; Stéphanie Wagner; Emile Andriambeloson; Vladimir T Ivashkin; Oleg I Epstein
Journal:  Dose Response       Date:  2018-06-26       Impact factor: 2.658

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.